Original Research Article
Oct. 30, 2017
Modeling and In-Silico Evaluation of Some Flavonoids as Cyclooxygenases Inhibitors Phytochemicalsognes
Haifaa Rasheed Muhsin
Sch Acad J Pharm | 413-422
DOI : 10.21276/sajp.2017.6.10.1
Abstract
PDF
Full Texts
e-Pub
In the inflammation process, the enzyme cyclooxygenase-2 expressed and its
function is prostaglandins synthesis of from arachidonic acid so that to inhibit
inflammation proses, COX-2 must be inhibited. In current research a twenty-six
flavonoids compounds included flavonols (n= 10), flavones (n= 7) and anthocyanins (n=
9) were studied to predict their affinity to attach to the active site of both COX-1 and
COX-2 enzymes and to predict the selectivity of each compound to COX-2, this done
using docking method. Docking simulation for each compound done using 1-click
docking tool. Some of the studied compound (n= 13 ) had strong predicted affinity to
COX-2 combined with strong affinity to COX-1, so that they are non-selective inhibitors,
additionally, an exception was found for Rosinidin and Pulchellidin which tends to bind
to COX-2 with stronger affinity than COX-1, as (-8.1, -7.6,) and (-6.5, -5.2, -2.8)
respectively.
Original Research Article
Oct. 30, 2017
Drug-Excipient Interaction Study of Lornoxicam with Polymers
Vaibhav Mhasal, Sumedh N. Moharil, Bhakti Mali, Mahesh B. Narkhede
Sch Acad J Pharm | 423-428
DOI : 10.21276/sajp.2017.6.10.2
Abstract
PDF
Full Texts
e-Pub
Interaction study is the most important step in reformulation study for the
preparation of all dosage forms. The interaction can affect physical, chemical, therapeutic
and biological properties and stability of drug and create a new surprise problem, the
successful formulation of stable and effective solid dosage form depends on the careful
and suitable choice of excipient. Also the selection of excipient is vital in the design of a
quality drug product. The quality of medicine depends not only on the active principals
and productions process, but also on the performance of the excipients .The present work
shows the interaction study of Lornoxicam and polymers for Nano products. In IR the
interaction of infrared radiation with matter. It covers range of techniques, mostly based
on absorption spectroscopy. DSC is a thermo-analytical technique in which the difference
in the amount of heat required to increase the temperature of sample and reference is
measured as a function of temperature.
Diagnosis of Myocardial Infarction by Biomarkers-A Review
G. Gnaneswar, B. Sudha Chandra, P. Priyanka, C. Gopinath
Sch Acad J Pharm | 429-433
DOI : 10.21276/sajp.2017.6.10.3
Abstract
PDF
Full Texts
e-Pub
Cardiovascular diseases are major causes for morbidity and mortality
worldwide, among this myocardial infarction is one of them. Myocardial infarction can be
diagnosed by physical examination of the patient, electrocardiogram, angiography and
biomarkers. Since 40 years, cardiac biomarkers were extensively using for diagnosis of
cardiac abnormalities. AST was the first biomarker used in year 1954. Myoglobin,
Creatinine kinase, Troponin, lactate dehydrogenase were established biomarkers and
Myeloperoxidase, Copeptin, Growth differentiation factor (GDR-15), Heart type fatty
acid-binding protein (H-FABP),B-type natri-uretic peptide(BNP) and N-terminal
fragement of pro-BNP, High sensitive C-reactive protein (hs-CRO), Placental growth
factor (PIGF), Whole blood choline(WBCHO) and plasma choline, Pentraxin 3(PTX-3),
Pregnancy associated plasma protein A(PAPPA), Soluble cluster of differentiation 40
ligand, Ischemia modified albumin(IMA) were emerging biomarkers. In this review we
mainly focused in the diagnostic and prognostic information of various biomarkers used
for diagnosis of myocardial infarction.
Case Series: Multiple Risk Factors Related Metabolic Syndrome
Buchi Reddy Kunduru, Hari hasanChunchu, Ramyakrishna Kalva, MahenderVatipelli
Sch Acad J Pharm | 434-439
DOI : 10.21276/sajp.2017.6.10.4
Abstract
PDF
Full Texts
e-Pub
Indians have a high prevalence of Metabolic Syndrome (MetS) which carries
multiple risk factors. Since a scarce information is available about the magnitude of
Metabolic Syndrome amongst the geriatric population in India. Present case was taken up
to ascertain the risk factors and management MetS. In this cases hypertension, T2DM,
insulin resistance, obesity, dyslipidemia, IHD, low sedentary life style activities, and nonadherence to the medications are the major contributing risk factors for MetS and it was
managed by the effective therapeutic regimens, supportive therapy and counselled the
patient about disease condition, medications usage, and life style modifications to
overcome or control the MetS.
Original Research Article
Oct. 30, 2017
Formulation and Evaluation of Pravastatin Sodium Transdermal Patch
Swathi Palepu, Balli Sravanthi, Donthu Hima bindu, Gollapally Venu Kumar, Jonnalagadda Rambabu, T. Satyanarayana
Sch Acad J Pharm | 440-445
DOI : 10.21276/sajp.2017.6.10.5
Abstract
PDF
Full Texts
e-Pub
The aim of the present study was to formulate and evaluate Pravastatin Sodium
transdermal patch. Pravastatin is a lipid lowering agent, because of its short biological
half life (t1/2, 1-3 hours) only 18% of its dose reaches to the systemic circulation of the
blood on oral administration. Hence it is a suitable drug to formulate into transdermal
form. Transdermal patchs of Pravastatin Sodium was prepared by using different
polymers like HPMC 3000, HPMC K15M,HPMC E5 by solvent casting method. FTIR
study reports have shown that there was no interaction between drug and excipients. The
prepared patches were evaluated for Folding Endurance, Uniformity of weight, Drug
content, Moisture content, In-vitro diffusion study, a series of 12 formulations were
prepared by using different polymers composition in different concentrations among them
F11 formulation prepared by using HPMC K15M was showed satisfactory results with
88.6% of drug release in diffusion studies was found to be suitable for formulating as
transdermal patch in order to increase the bioavailability and to decrease the dosing
frequency of Pravastatin Sodium.